PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Global Health Neurology and Translational Neuroscience Laboratory, Sydney and Neurovascular Imaging Laboratory, Clinical Sciences Stream, Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.\', \'University of New South Wales (UNSW), South-Western Sydney Clinical School, Sydney, New South Wales, Australia.\', \'Polish Mother\'s Memorial Hospital Research Institute and Department of Hypertension, Medical University of Lodz, Lodz, Poland.\', \'Cardiovascular Research Centre, University of Zielona Góra, Zielona Gora, Poland.\', \'Peripheral Neurophysiology Service, NEUROMED-Argentina, Godoy Cruz, Argentina.\', \'Department of Neurophysiology, Mendoza Medical Center, Godoy Cruz, Argentina.\', \'University Clinic of Endocrinology, Diabetes and Metabolic Disorders Skopje, Faculty of Medical Sciences, University Goce Delčev Štip, Štip, North Macedonia.\', \'NSW Brain Clot Bank, New South Wales Health Pathology, Sydney, New South Wales, Australia.\', \'Department of Neurology and Neurophysiology, Comprehensive Stroke Center, Liverpool Hospital and South-Western Sydney Local Health District, Sydney, New South Wales, Australia.\', \'Stroke and Neurology Research Group, Ingham Institute for Applied Medical Research, Liverpool, New South Wales, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/1753-0407.13243
?:hasPublicationType
?:journal
  • Journal of diabetes
is ?:pmid of
?:pmid
?:pmid
  • 34939735
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.947
?:rankingScore_hIndex
  • 32
is ?:relation_isRelatedTo_publication of
?:title
  • Prevalence and impact of diabetes in hospitalized COVID-19 patients: A systematic review and meta-analysis.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all